This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

GLP-1 is a natural human hormone that regulates blood glucose levels. Scientists have now created long-lasting GLP-1 drugs ...

GLP-1 receptor agonist therapy reduced surgical abscess repairs and hospitalizations among people with hidradenitis ...

GLP-1 receptor agonists may reduce glaucoma risk in T2D patients, though the reduction was nonsignificant. The review included five high-quality observational studies with over 2.5 million ...

Psoriasis and psoriatic arthritis (PsA) are chronic, immune-mediated inflammatory diseases associated with several shared common comorbidities, of which obesity is one of the most prevalent. A complex ...

SaveHealth reports that Zepbound and Wegovy, both FDA-approved weight loss injectables, differ in mechanisms and efficacy.

SEATTLE -- GLP-1 receptor agonist use was tied with a reduced risk for fracture among older women with type 2 diabetes, a retrospective cohort study found. Among over 350,000 GLP-1 users, there was a ...

When you factor in those hurdles, it’s fair to wonder how close we are to GLP-1 pills. Turns out, there is already a GLP-1 ...

More than twofold increased risk seen for nAMD development in unadjusted and adjusted models. HealthDay News — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 ...

CONSHOHOCKEN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal”) today announced that it has entered into an exclusive global license agreement with CSPC ...